

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44981822 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44981822 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 3.95314331 |
| 4 | purine nucleobase biosynthetic process (GO:0009113) | 3.93799194 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87706270 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84750728 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 3.78445767 |
| 8 | branched-chain amino acid catabolic process (GO:0009083) | 3.65739407 |
| 9 | ribosomal large subunit biogenesis (GO:0042273) | 3.59634496 |
| 10 | ribosome assembly (GO:0042255) | 3.59369044 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59321929 |
| 12 | regulation of mitochondrial translation (GO:0070129) | 3.52296102 |
| 13 | formation of translation preinitiation complex (GO:0001731) | 3.44652209 |
| 14 | oxidative phosphorylation (GO:0006119) | 3.43768229 |
| 15 | proteasome assembly (GO:0043248) | 3.43524158 |
| 16 | CENP-A containing nucleosome assembly (GO:0034080) | 3.42626885 |
| 17 | mitochondrial DNA replication (GO:0006264) | 3.41782083 |
| 18 | interferon-gamma production (GO:0032609) | 3.37792523 |
| 19 | chromatin remodeling at centromere (GO:0031055) | 3.36810303 |
| 20 | lactate metabolic process (GO:0006089) | 3.34969930 |
| 21 | nucleobase biosynthetic process (GO:0046112) | 3.34325642 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.32781670 |
| 23 | valine metabolic process (GO:0006573) | 3.26232560 |
| 24 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22382812 |
| 25 | AMP metabolic process (GO:0046033) | 3.20904788 |
| 26 | NADH metabolic process (GO:0006734) | 3.20148426 |
| 27 | L-serine metabolic process (GO:0006563) | 3.16969326 |
| 28 | definitive hemopoiesis (GO:0060216) | 3.16798929 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16661343 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.14141121 |
| 31 | DNA replication checkpoint (GO:0000076) | 3.13065723 |
| 32 | tricarboxylic acid cycle (GO:0006099) | 3.12299940 |
| 33 | respiratory chain complex IV assembly (GO:0008535) | 3.09727977 |
| 34 | mitotic recombination (GO:0006312) | 3.08214639 |
| 35 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.06574803 |
| 36 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03497990 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02827288 |
| 38 | regulation of helicase activity (GO:0051095) | 2.91932243 |
| 39 | negative regulation of ligase activity (GO:0051352) | 2.91210759 |
| 40 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.91210759 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91120136 |
| 42 | branched-chain amino acid metabolic process (GO:0009081) | 2.90432288 |
| 43 | aldehyde catabolic process (GO:0046185) | 2.86758484 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.84106865 |
| 45 | L-phenylalanine catabolic process (GO:0006559) | 2.84106865 |
| 46 | histone exchange (GO:0043486) | 2.83162881 |
| 47 | establishment of viral latency (GO:0019043) | 2.82163871 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81340176 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 2.81340176 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.80600791 |
| 51 | aromatic amino acid family catabolic process (GO:0009074) | 2.80344125 |
| 52 | rRNA modification (GO:0000154) | 2.80323338 |
| 53 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79307888 |
| 54 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.77892657 |
| 55 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.77748024 |
| 56 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.77748024 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 2.74049607 |
| 58 | tryptophan catabolic process (GO:0006569) | 2.74049607 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 2.74049607 |
| 60 | peptidyl-histidine modification (GO:0018202) | 2.73557216 |
| 61 | tryptophan metabolic process (GO:0006568) | 2.73023524 |
| 62 | rRNA methylation (GO:0031167) | 2.71629333 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 2.71019437 |
| 64 | telomere maintenance via telomere lengthening (GO:0010833) | 2.69652767 |
| 65 | translation (GO:0006412) | 2.67572514 |
| 66 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65529980 |
| 67 | translational initiation (GO:0006413) | 2.65498506 |
| 68 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.61959390 |
| 69 | non-recombinational repair (GO:0000726) | 2.61959390 |
| 70 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.59948645 |
| 71 | L-ascorbic acid metabolic process (GO:0019852) | 2.59837683 |
| 72 | ethanol oxidation (GO:0006069) | 2.59206881 |
| 73 | cytochrome complex assembly (GO:0017004) | 2.59070640 |
| 74 | regulation of B cell differentiation (GO:0045577) | 2.58819605 |
| 75 | fatty acid homeostasis (GO:0055089) | 2.58127955 |
| 76 | mitotic G2/M transition checkpoint (GO:0044818) | 2.57813203 |
| 77 | DNA double-strand break processing (GO:0000729) | 2.56962805 |
| 78 | mitochondrial DNA metabolic process (GO:0032042) | 2.56694395 |
| 79 | DNA replication-independent nucleosome organization (GO:0034724) | 2.56606844 |
| 80 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.56606844 |
| 81 | glucuronate metabolic process (GO:0019585) | 2.56592926 |
| 82 | uronic acid metabolic process (GO:0006063) | 2.56592926 |
| 83 | positive regulation of ligase activity (GO:0051351) | 2.55187421 |
| 84 | protein carboxylation (GO:0018214) | 2.53015349 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53015349 |
| 86 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.52930841 |
| 87 | glyoxylate metabolic process (GO:0046487) | 2.52692031 |
| 88 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.52164343 |
| 89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49994464 |
| 90 | DNA ligation (GO:0006266) | 2.48780927 |
| 91 | ribosomal small subunit biogenesis (GO:0042274) | 2.48693224 |
| 92 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.47920248 |
| 93 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.46895699 |
| 94 | DNA unwinding involved in DNA replication (GO:0006268) | 2.46659993 |
| 95 | ATP synthesis coupled proton transport (GO:0015986) | 2.46041912 |
| 96 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.46041912 |
| 97 | oxaloacetate metabolic process (GO:0006107) | 2.45127491 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 2.45113800 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.45059954 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.45059954 |
| 101 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.45059954 |
| 102 | maturation of SSU-rRNA (GO:0030490) | 2.44991064 |
| 103 | necroptotic process (GO:0070266) | 2.44111140 |
| 104 | ethanol metabolic process (GO:0006067) | 2.43686260 |
| 105 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.42902155 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 2.42624530 |
| 107 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.42471626 |
| 108 | kynurenine metabolic process (GO:0070189) | 2.42251629 |
| 109 | urate metabolic process (GO:0046415) | 2.42021602 |
| 110 | glycine metabolic process (GO:0006544) | 2.41639110 |
| 111 | negative T cell selection (GO:0043383) | 2.40030356 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39819251 |
| 113 | bile acid biosynthetic process (GO:0006699) | 2.38909744 |
| 114 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.38888321 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.38346170 |
| 116 | urea metabolic process (GO:0019627) | 2.35200396 |
| 117 | urea cycle (GO:0000050) | 2.35200396 |
| 118 | DNA strand elongation (GO:0022616) | 2.35111932 |
| 119 | signal peptide processing (GO:0006465) | 2.34876595 |
| 120 | IMP biosynthetic process (GO:0006188) | 2.34851595 |
| 121 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.32776914 |
| 122 | lysine catabolic process (GO:0006554) | 2.32692163 |
| 123 | lysine metabolic process (GO:0006553) | 2.32692163 |
| 124 | tetrahydrofolate metabolic process (GO:0046653) | 2.31572984 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.30929465 |
| 126 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.30116667 |
| 127 | cysteine metabolic process (GO:0006534) | 2.29831898 |
| 128 | DNA replication initiation (GO:0006270) | 2.29828901 |
| 129 | IMP metabolic process (GO:0046040) | 2.29711809 |
| 130 | folic acid metabolic process (GO:0046655) | 2.28969828 |
| 131 | response to interferon-beta (GO:0035456) | 2.28955454 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.25318715 |
| 133 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.24913164 |
| 134 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.24153555 |
| 135 | telomere maintenance via recombination (GO:0000722) | 2.23019963 |
| 136 | viral transcription (GO:0019083) | 2.22935379 |
| 137 | hepatocyte apoptotic process (GO:0097284) | 2.21199959 |
| 138 | cotranslational protein targeting to membrane (GO:0006613) | 2.20526821 |
| 139 | protein targeting to ER (GO:0045047) | 2.20422192 |
| 140 | mature B cell differentiation involved in immune response (GO:0002313) | 2.19808998 |
| 141 | amino-acid betaine metabolic process (GO:0006577) | 2.19221837 |
| 142 | alpha-linolenic acid metabolic process (GO:0036109) | 2.19014131 |
| 143 | translational termination (GO:0006415) | 2.18661278 |
| 144 | regulation of triglyceride catabolic process (GO:0010896) | 2.16750427 |
| 145 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.15407027 |
| 146 | imidazole-containing compound metabolic process (GO:0052803) | 2.14232639 |
| 147 | B cell mediated immunity (GO:0019724) | 2.14031265 |
| 148 | pteridine-containing compound metabolic process (GO:0042558) | 2.13380485 |
| 149 | serine family amino acid metabolic process (GO:0009069) | 2.12836414 |
| 150 | drug transmembrane transport (GO:0006855) | 2.12394053 |
| 151 | positive regulation of interferon-alpha production (GO:0032727) | 2.11458779 |
| 152 | drug transport (GO:0015893) | 2.10393640 |
| 153 | protein localization to endoplasmic reticulum (GO:0070972) | 2.10165465 |
| 154 | cellular glucuronidation (GO:0052695) | 2.09304692 |
| 155 | folic acid-containing compound metabolic process (GO:0006760) | 2.09157018 |
| 156 | regulation of response to interferon-gamma (GO:0060330) | 2.09052223 |
| 157 | leukocyte aggregation (GO:0070486) | 2.09022633 |
| 158 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.08369355 |
| 159 | one-carbon metabolic process (GO:0006730) | 2.08334349 |
| 160 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.07489859 |
| 161 | translesion synthesis (GO:0019985) | 2.06751653 |
| 162 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.06321240 |
| 163 | nitrogen cycle metabolic process (GO:0071941) | 2.06111212 |
| 164 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.05612515 |
| 165 | NIK/NF-kappaB signaling (GO:0038061) | 2.05501790 |
| 166 | mast cell activation (GO:0045576) | 2.05416121 |
| 167 | complement activation, alternative pathway (GO:0006957) | 2.05252097 |
| 168 | blood coagulation, intrinsic pathway (GO:0007597) | 2.04384569 |
| 169 | regulation of interferon-alpha production (GO:0032647) | 2.04083982 |
| 170 | immunoglobulin mediated immune response (GO:0016064) | 2.04001951 |
| 171 | negative regulation of phagocytosis (GO:0050765) | 2.03340334 |
| 172 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.02556908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.46156498 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.48374971 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.23775535 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08959044 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.72618914 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71428656 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.57875091 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.49523105 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44995547 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.42536958 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.42154979 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41727500 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39239634 |
| 14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.36018201 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32313987 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31235330 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30209961 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.22477876 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.14783672 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.08358459 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02767957 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02482107 |
| 23 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98220655 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.96266341 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96104957 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96033854 |
| 27 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.95624480 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89650796 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88520661 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86722398 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80513726 |
| 32 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.79428037 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76765435 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.72251950 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.71980511 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71970026 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.71495889 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68496325 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67652702 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63767899 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.62689227 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62642498 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.62370179 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61887220 |
| 45 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61731068 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.61365176 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60752359 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60715358 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.59616110 |
| 50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56903969 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56477090 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56445563 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55858880 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53755760 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53144247 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52676850 |
| 57 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.52447737 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49559448 |
| 59 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49488986 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.48535388 |
| 61 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.46103799 |
| 62 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44144288 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43671794 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43567002 |
| 65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43419487 |
| 66 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.42830453 |
| 67 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42702581 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42006636 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40735013 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40436087 |
| 71 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40359265 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40151342 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39008791 |
| 74 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37758660 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37574360 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35181324 |
| 77 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34535581 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34469856 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34373781 |
| 80 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34012987 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.33428241 |
| 82 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31291646 |
| 83 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31240171 |
| 84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30783712 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29741052 |
| 86 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29261768 |
| 87 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.28951532 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28359847 |
| 89 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27991033 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27607657 |
| 91 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26858110 |
| 92 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22608645 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21480552 |
| 94 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21065360 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20914156 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20411699 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20275644 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.18578765 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18513937 |
| 100 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.18198565 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17538193 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16941873 |
| 103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.16330731 |
| 104 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.15131126 |
| 105 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14569771 |
| 106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14187335 |
| 107 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14170803 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13108078 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.12606380 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11917841 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11404574 |
| 112 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10436140 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10081116 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09899481 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09557226 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07998706 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07519850 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06662509 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05978543 |
| 120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05712959 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04832416 |
| 122 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03488445 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02933053 |
| 124 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.02314693 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00980531 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00737988 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00165448 |
| 128 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.00088345 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99724462 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99202650 |
| 131 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.98872298 |
| 132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97583611 |
| 133 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96801828 |
| 134 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93851959 |
| 135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93365655 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.91489313 |
| 137 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90276728 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88968251 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87936443 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87160178 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86478313 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86341050 |
| 143 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85968825 |
| 144 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85180590 |
| 145 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84111708 |
| 146 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81822878 |
| 147 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80994289 |
| 148 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.80811937 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80197636 |
| 150 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.79609515 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79529874 |
| 152 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78129923 |
| 153 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78063389 |
| 154 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78063389 |
| 155 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.77026643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003941_abnormal_skin_development | 3.52243516 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.12063708 |
| 3 | MP0005360_urolithiasis | 3.05034328 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.80353440 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.65925881 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.60289266 |
| 7 | MP0005365_abnormal_bile_salt | 2.54868682 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.49936458 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.46673109 |
| 10 | MP0005671_abnormal_response_to | 2.31898630 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.31262288 |
| 12 | MP0003436_decreased_susceptibility_to | 2.27611911 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.20395121 |
| 14 | MP0001661_extended_life_span | 2.11535568 |
| 15 | MP0009785_altered_susceptibility_to | 2.04975294 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.02507088 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.97292652 |
| 18 | MP0000685_abnormal_immune_system | 1.96482032 |
| 19 | MP0003724_increased_susceptibility_to | 1.91486603 |
| 20 | MP0001800_abnormal_humoral_immune | 1.89957768 |
| 21 | MP0003718_maternal_effect | 1.88646222 |
| 22 | MP0008877_abnormal_DNA_methylation | 1.79108821 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.76987624 |
| 24 | MP0002398_abnormal_bone_marrow | 1.71427653 |
| 25 | MP0006054_spinal_hemorrhage | 1.70467940 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.69063431 |
| 27 | MP0003195_calcinosis | 1.68296354 |
| 28 | MP0005025_abnormal_response_to | 1.67500756 |
| 29 | MP0002723_abnormal_immune_serum | 1.66374756 |
| 30 | MP0002163_abnormal_gland_morphology | 1.66103269 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.65221422 |
| 32 | MP0001873_stomach_inflammation | 1.64712696 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.63092502 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.62062661 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.61580881 |
| 36 | MP0001819_abnormal_immune_cell | 1.59657800 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.59139951 |
| 38 | MP0001853_heart_inflammation | 1.58490508 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.56902567 |
| 40 | MP0005408_hypopigmentation | 1.56209321 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.54877121 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.54877121 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.54339850 |
| 44 | MP0005387_immune_system_phenotype | 1.52301193 |
| 45 | MP0001790_abnormal_immune_system | 1.52301193 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.49601511 |
| 47 | MP0002722_abnormal_immune_system | 1.49086288 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.48861318 |
| 49 | MP0002419_abnormal_innate_immunity | 1.48439422 |
| 50 | MP0002006_tumorigenesis | 1.47527118 |
| 51 | MP0002405_respiratory_system_inflammati | 1.46556148 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.45654013 |
| 53 | MP0000716_abnormal_immune_system | 1.45523108 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.45193502 |
| 55 | MP0008057_abnormal_DNA_replication | 1.45135051 |
| 56 | MP0001764_abnormal_homeostasis | 1.44508106 |
| 57 | MP0003186_abnormal_redox_activity | 1.43952017 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.43837757 |
| 59 | MP0006082_CNS_inflammation | 1.43390322 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.42790061 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.41367501 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.39869910 |
| 63 | MP0003252_abnormal_bile_duct | 1.39607375 |
| 64 | MP0001984_abnormal_olfaction | 1.38926783 |
| 65 | MP0001730_embryonic_growth_arrest | 1.38885822 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.38553760 |
| 67 | MP0000609_abnormal_liver_physiology | 1.38342965 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.38031749 |
| 69 | MP0008469_abnormal_protein_level | 1.37953492 |
| 70 | MP0008932_abnormal_embryonic_tissue | 1.36824190 |
| 71 | MP0009697_abnormal_copulation | 1.36795010 |
| 72 | MP0002429_abnormal_blood_cell | 1.36268659 |
| 73 | MP0009840_abnormal_foam_cell | 1.35875682 |
| 74 | MP0000490_abnormal_crypts_of | 1.33499612 |
| 75 | MP0010094_abnormal_chromosome_stability | 1.32768442 |
| 76 | MP0003123_paternal_imprinting | 1.32705165 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.32482418 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.31800959 |
| 79 | MP0005330_cardiomyopathy | 1.30583340 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.30145793 |
| 81 | MP0008007_abnormal_cellular_replicative | 1.27210486 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.26120812 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 1.25231178 |
| 84 | MP0001666_abnormal_nutrient_absorption | 1.24953756 |
| 85 | MP0004215_abnormal_myocardial_fiber | 1.24672278 |
| 86 | MP0003868_abnormal_feces_composition | 1.22556941 |
| 87 | MP0002933_joint_inflammation | 1.20661462 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.20227920 |
| 89 | MP0005332_abnormal_amino_acid | 1.19926270 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 1.19747060 |
| 91 | MP0009672_abnormal_birth_weight | 1.19722974 |
| 92 | MP0002090_abnormal_vision | 1.19057166 |
| 93 | MP0000372_irregular_coat_pigmentation | 1.19034369 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 1.18525583 |
| 95 | MP0009643_abnormal_urine_homeostasis | 1.18437122 |
| 96 | MP0000703_abnormal_thymus_morphology | 1.16038240 |
| 97 | MP0002160_abnormal_reproductive_system | 1.14337834 |
| 98 | MP0004947_skin_inflammation | 1.13960925 |
| 99 | MP0000350_abnormal_cell_proliferation | 1.11679878 |
| 100 | MP0004147_increased_porphyrin_level | 1.11482938 |
| 101 | MP0000383_abnormal_hair_follicle | 1.09130377 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 1.09100320 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.08980440 |
| 104 | MP0000598_abnormal_liver_morphology | 1.08820906 |
| 105 | MP0009763_increased_sensitivity_to | 1.06847850 |
| 106 | MP0003077_abnormal_cell_cycle | 1.06742547 |
| 107 | MP0001697_abnormal_embryo_size | 1.04238178 |
| 108 | MP0002019_abnormal_tumor_incidence | 1.01351408 |
| 109 | MP0009780_abnormal_chondrocyte_physiolo | 1.01195464 |
| 110 | MP0003866_abnormal_defecation | 1.01111923 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.99231551 |
| 112 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98789100 |
| 113 | MP0008058_abnormal_DNA_repair | 0.98383026 |
| 114 | MP0000858_altered_metastatic_potential | 0.98273998 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.96407246 |
| 116 | MP0009764_decreased_sensitivity_to | 0.94866903 |
| 117 | MP0002132_abnormal_respiratory_system | 0.92871049 |
| 118 | MP0005023_abnormal_wound_healing | 0.92518474 |
| 119 | MP0001293_anophthalmia | 0.91887286 |
| 120 | MP0005380_embryogenesis_phenotype | 0.90448414 |
| 121 | MP0001672_abnormal_embryogenesis/_devel | 0.90448414 |
| 122 | MP0004957_abnormal_blastocyst_morpholog | 0.90124917 |
| 123 | MP0003111_abnormal_nucleus_morphology | 0.86997876 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86358772 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.85861467 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.85360805 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.85019098 |
| 128 | MP0000343_altered_response_to | 0.84168366 |
| 129 | MP0002088_abnormal_embryonic_growth/wei | 0.83131888 |
| 130 | MP0005395_other_phenotype | 0.82921324 |
| 131 | MP0003984_embryonic_growth_retardation | 0.82817668 |
| 132 | MP0002009_preneoplasia | 0.82227853 |
| 133 | MP0000358_abnormal_cell_content/ | 0.81875530 |
| 134 | MP0002118_abnormal_lipid_homeostasis | 0.81715623 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.78839016 |
| 136 | MP0003315_abnormal_perineum_morphology | 0.78833254 |
| 137 | MP0002254_reproductive_system_inflammat | 0.77436084 |
| 138 | MP0002796_impaired_skin_barrier | 0.76644090 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.76407250 |
| 140 | MP0000462_abnormal_digestive_system | 0.75668679 |
| 141 | MP0004019_abnormal_vitamin_homeostasis | 0.75418224 |
| 142 | MP0001929_abnormal_gametogenesis | 0.75309359 |
| 143 | MP0002080_prenatal_lethality | 0.74774777 |
| 144 | MP0001881_abnormal_mammary_gland | 0.74769670 |
| 145 | MP0003011_delayed_dark_adaptation | 0.74672837 |
| 146 | MP0000313_abnormal_cell_death | 0.74645516 |
| 147 | MP0000371_diluted_coat_color | 0.74267118 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.73627584 |
| 149 | MP0001145_abnormal_male_reproductive | 0.72966791 |
| 150 | MP0005636_abnormal_mineral_homeostasis | 0.72536729 |
| 151 | MP0002877_abnormal_melanocyte_morpholog | 0.72265305 |
| 152 | MP0003786_premature_aging | 0.72208767 |
| 153 | MP0005310_abnormal_salivary_gland | 0.70632525 |
| 154 | MP0002084_abnormal_developmental_patter | 0.70163029 |
| 155 | MP0009703_decreased_birth_body | 0.68001580 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.67234495 |
| 157 | MP0005220_abnormal_exocrine_pancreas | 0.66250987 |
| 158 | MP0002269_muscular_atrophy | 0.64499419 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.63962006 |
| 160 | MP0002693_abnormal_pancreas_physiology | 0.63375939 |
| 161 | MP0008872_abnormal_physiological_respon | 0.63098452 |
| 162 | MP0000477_abnormal_intestine_morphology | 0.61330541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 4.77786807 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.29920241 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.43422590 |
| 4 | Thrombocytosis (HP:0001894) | 3.37839402 |
| 5 | Lipid accumulation in hepatocytes (HP:0006561) | 3.35536728 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 3.25215492 |
| 7 | Hyperglycinuria (HP:0003108) | 3.20156535 |
| 8 | Symptomatic seizures (HP:0011145) | 3.19084602 |
| 9 | Myositis (HP:0100614) | 3.17668520 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16644817 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 3.16644817 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.13237381 |
| 13 | Hyperglycinemia (HP:0002154) | 3.12637350 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.05770647 |
| 15 | IgM deficiency (HP:0002850) | 3.01472900 |
| 16 | Gout (HP:0001997) | 2.96075948 |
| 17 | Joint hemorrhage (HP:0005261) | 2.93675946 |
| 18 | Epistaxis (HP:0000421) | 2.89515271 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 2.85233779 |
| 20 | Petechiae (HP:0000967) | 2.83691221 |
| 21 | Hepatic necrosis (HP:0002605) | 2.83579387 |
| 22 | Abnormality of serum amino acid levels (HP:0003112) | 2.83023078 |
| 23 | Methylmalonic acidemia (HP:0002912) | 2.82087085 |
| 24 | Increased serum pyruvate (HP:0003542) | 2.81722886 |
| 25 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.80054947 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79361034 |
| 27 | Ketoacidosis (HP:0001993) | 2.78067089 |
| 28 | Glycosuria (HP:0003076) | 2.75745551 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 2.75745551 |
| 30 | Aplastic anemia (HP:0001915) | 2.75314803 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.70833467 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.70833467 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.70539704 |
| 34 | Microvesicular hepatic steatosis (HP:0001414) | 2.69121187 |
| 35 | Impaired platelet aggregation (HP:0003540) | 2.68041777 |
| 36 | Abnormal platelet function (HP:0011869) | 2.68041777 |
| 37 | Gingival bleeding (HP:0000225) | 2.65302239 |
| 38 | Chronic bronchitis (HP:0004469) | 2.64986425 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.64482152 |
| 40 | Abnormality of glycolysis (HP:0004366) | 2.62654625 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62523112 |
| 42 | Megaloblastic anemia (HP:0001889) | 2.59165757 |
| 43 | Orchitis (HP:0100796) | 2.58639682 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.58507605 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.57089643 |
| 46 | Recurrent viral infections (HP:0004429) | 2.55419433 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.55026211 |
| 48 | Myoglobinuria (HP:0002913) | 2.54144204 |
| 49 | Cerebral edema (HP:0002181) | 2.52977114 |
| 50 | Abnormal platelet volume (HP:0011876) | 2.51699456 |
| 51 | Abnormality of T cells (HP:0002843) | 2.50478520 |
| 52 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.47776657 |
| 53 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.47776657 |
| 54 | Abnormality of vitamin B metabolism (HP:0004340) | 2.47746630 |
| 55 | T lymphocytopenia (HP:0005403) | 2.47181472 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.46583656 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46268337 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 2.44995415 |
| 59 | Chromsome breakage (HP:0040012) | 2.44918699 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.44838136 |
| 61 | Optic neuritis (HP:0100653) | 2.44838136 |
| 62 | Macrocytic anemia (HP:0001972) | 2.44548800 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.43498033 |
| 64 | Abnormality of vitamin metabolism (HP:0100508) | 2.43124054 |
| 65 | Acute encephalopathy (HP:0006846) | 2.42493984 |
| 66 | Deep venous thrombosis (HP:0002625) | 2.40094490 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.39271297 |
| 68 | Palpitations (HP:0001962) | 2.38140650 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.38037359 |
| 70 | Abnormal foot bone ossification (HP:0010675) | 2.37045556 |
| 71 | Chronic otitis media (HP:0000389) | 2.36257773 |
| 72 | Increased CSF lactate (HP:0002490) | 2.35426706 |
| 73 | Hepatocellular necrosis (HP:0001404) | 2.34108682 |
| 74 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.33638171 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.33048685 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 2.32845354 |
| 77 | Encephalitis (HP:0002383) | 2.32310558 |
| 78 | Xanthomatosis (HP:0000991) | 2.32000934 |
| 79 | Arterial thrombosis (HP:0004420) | 2.31468083 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.31011486 |
| 81 | Rhinitis (HP:0012384) | 2.29785506 |
| 82 | Hypoplasia of the thymus (HP:0000778) | 2.29485172 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.27914085 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27914085 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.25912527 |
| 86 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25564603 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.24107077 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.23933844 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.23684611 |
| 90 | Recurrent abscess formation (HP:0002722) | 2.23532761 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.23321357 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.22983252 |
| 93 | Bronchiectasis (HP:0002110) | 2.22896739 |
| 94 | Metaphyseal cupping (HP:0003021) | 2.22707551 |
| 95 | Thrombophlebitis (HP:0004418) | 2.22173506 |
| 96 | Hypoglycemic coma (HP:0001325) | 2.20403424 |
| 97 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.19094741 |
| 98 | Menorrhagia (HP:0000132) | 2.18872783 |
| 99 | Eczematoid dermatitis (HP:0000976) | 2.18342439 |
| 100 | Colon cancer (HP:0003003) | 2.16915913 |
| 101 | Recurrent fungal infections (HP:0002841) | 2.15624498 |
| 102 | Hyperammonemia (HP:0001987) | 2.15498257 |
| 103 | Recurrent bacterial skin infections (HP:0005406) | 2.14340454 |
| 104 | Abnormality of methionine metabolism (HP:0010901) | 2.14292967 |
| 105 | Proximal tubulopathy (HP:0000114) | 2.13836486 |
| 106 | Lactic acidosis (HP:0003128) | 2.13288384 |
| 107 | Anorexia (HP:0002039) | 2.12919940 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11953119 |
| 109 | Hyperglycemia (HP:0003074) | 2.11825017 |
| 110 | Fat malabsorption (HP:0002630) | 2.10380236 |
| 111 | Generalized aminoaciduria (HP:0002909) | 2.10231811 |
| 112 | Metabolic acidosis (HP:0001942) | 2.09315545 |
| 113 | Keratoconjunctivitis (HP:0001096) | 2.09306853 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09179623 |
| 115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.07538807 |
| 116 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.07538807 |
| 117 | Abnormal protein glycosylation (HP:0012346) | 2.07538807 |
| 118 | Abnormal glycosylation (HP:0012345) | 2.07538807 |
| 119 | Spontaneous hematomas (HP:0007420) | 2.07468236 |
| 120 | Renal cortical cysts (HP:0000803) | 2.06830947 |
| 121 | Progressive macrocephaly (HP:0004481) | 2.06540115 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 2.06526861 |
| 123 | Exercise intolerance (HP:0003546) | 2.06325113 |
| 124 | Joint swelling (HP:0001386) | 2.05060524 |
| 125 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04963131 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 2.04331476 |
| 127 | Lethargy (HP:0001254) | 2.03861185 |
| 128 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03683127 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 2.03487307 |
| 130 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03482855 |
| 131 | Abnormal ciliary motility (HP:0012262) | 2.03156825 |
| 132 | Methylmalonic aciduria (HP:0012120) | 2.03009420 |
| 133 | Abnormality of the prostate (HP:0008775) | 2.02257584 |
| 134 | Increased serum lactate (HP:0002151) | 2.01939975 |
| 135 | Nasal polyposis (HP:0100582) | 2.00682759 |
| 136 | Irregular epiphyses (HP:0010582) | 2.00305093 |
| 137 | Exercise-induced muscle cramps (HP:0003710) | 1.97049820 |
| 138 | Autoimmune hemolytic anemia (HP:0001890) | 1.96356843 |
| 139 | Hyperlipoproteinemia (HP:0010980) | 1.94621688 |
| 140 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94357643 |
| 141 | Hyperphosphaturia (HP:0003109) | 1.94212079 |
| 142 | Beaking of vertebral bodies (HP:0004568) | 1.93692670 |
| 143 | Purpura (HP:0000979) | 1.93250862 |
| 144 | Biliary tract neoplasm (HP:0100574) | 1.92898347 |
| 145 | Granulocytopenia (HP:0001913) | 1.92733339 |
| 146 | Rhabdomyosarcoma (HP:0002859) | 1.92720776 |
| 147 | Exertional dyspnea (HP:0002875) | 1.91488820 |
| 148 | Reticulocytopenia (HP:0001896) | 1.91142913 |
| 149 | Absent/shortened dynein arms (HP:0200106) | 1.90823835 |
| 150 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90823835 |
| 151 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89706148 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 1.88831963 |
| 153 | Abnormality of nucleobase metabolism (HP:0010932) | 1.88270854 |
| 154 | Complement deficiency (HP:0004431) | 1.88192997 |
| 155 | Meningitis (HP:0001287) | 1.87754109 |
| 156 | 11 pairs of ribs (HP:0000878) | 1.87439990 |
| 157 | Hepatocellular carcinoma (HP:0001402) | 1.86451882 |
| 158 | Panhypogammaglobulinemia (HP:0003139) | 1.85990980 |
| 159 | Steatorrhea (HP:0002570) | 1.85715434 |
| 160 | Pulmonary embolism (HP:0002204) | 1.85237072 |
| 161 | Renal Fanconi syndrome (HP:0001994) | 1.84242902 |
| 162 | Vasculitis (HP:0002633) | 1.83930948 |
| 163 | Ketosis (HP:0001946) | 1.83898195 |
| 164 | Oral leukoplakia (HP:0002745) | 1.83878588 |
| 165 | Bronchitis (HP:0012387) | 1.83800874 |
| 166 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83632081 |
| 167 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83632081 |
| 168 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83511222 |
| 169 | Chronic diarrhea (HP:0002028) | 1.83028973 |
| 170 | Pustule (HP:0200039) | 1.82600404 |
| 171 | Neoplasm of the adrenal gland (HP:0100631) | 1.82434601 |
| 172 | Combined immunodeficiency (HP:0005387) | 1.81385679 |
| 173 | Acute myeloid leukemia (HP:0004808) | 1.81246062 |
| 174 | IgG deficiency (HP:0004315) | 1.81030827 |
| 175 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80794321 |
| 176 | Abnormality of chromosome stability (HP:0003220) | 1.80728261 |
| 177 | Progressive external ophthalmoplegia (HP:0000590) | 1.79152874 |
| 178 | Respiratory failure (HP:0002878) | 1.79068163 |
| 179 | B lymphocytopenia (HP:0010976) | 1.77776246 |
| 180 | Abnormality of B cell number (HP:0010975) | 1.77776246 |
| 181 | Pulmonary infiltrates (HP:0002113) | 1.77741328 |
| 182 | Epiphyseal dysplasia (HP:0002656) | 1.77430173 |
| 183 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76834748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 3.53791215 |
| 2 | MAP4K1 | 3.42008952 |
| 3 | VRK2 | 2.75754472 |
| 4 | FLT3 | 2.70818928 |
| 5 | TTK | 2.67184877 |
| 6 | TXK | 2.56749503 |
| 7 | ZAK | 2.44581841 |
| 8 | TEC | 2.44309853 |
| 9 | TAF1 | 2.27062191 |
| 10 | MAP2K3 | 2.23370122 |
| 11 | TGFBR2 | 2.20924160 |
| 12 | KIT | 2.13308590 |
| 13 | NME2 | 2.07969951 |
| 14 | JAK3 | 2.04745455 |
| 15 | STK38L | 2.04158320 |
| 16 | STK10 | 1.99271822 |
| 17 | NEK1 | 1.98240469 |
| 18 | BTK | 1.92652487 |
| 19 | ZAP70 | 1.91909279 |
| 20 | TYK2 | 1.90074624 |
| 21 | TGFBR1 | 1.87861262 |
| 22 | ERN1 | 1.83826749 |
| 23 | TIE1 | 1.81053625 |
| 24 | PLK3 | 1.74131747 |
| 25 | BCKDK | 1.73406655 |
| 26 | MAP3K3 | 1.68922899 |
| 27 | CDK8 | 1.64262522 |
| 28 | IKBKE | 1.63228412 |
| 29 | ITK | 1.62144368 |
| 30 | TBK1 | 1.61010402 |
| 31 | MAP3K14 | 1.59666267 |
| 32 | MAP3K12 | 1.56697017 |
| 33 | FGFR4 | 1.49898813 |
| 34 | IRAK4 | 1.46727991 |
| 35 | TAOK3 | 1.45967691 |
| 36 | NME1 | 1.45190621 |
| 37 | EEF2K | 1.44167898 |
| 38 | PKN2 | 1.41010339 |
| 39 | WEE1 | 1.40650744 |
| 40 | CSF1R | 1.40287613 |
| 41 | KDR | 1.36953952 |
| 42 | BMPR1B | 1.35849678 |
| 43 | PASK | 1.33170425 |
| 44 | PIM1 | 1.31661514 |
| 45 | RPS6KB2 | 1.28897456 |
| 46 | IKBKB | 1.25231621 |
| 47 | NEK9 | 1.24140938 |
| 48 | RPS6KA4 | 1.22534564 |
| 49 | PIM2 | 1.20923834 |
| 50 | PIK3CG | 1.20544218 |
| 51 | NLK | 1.20347995 |
| 52 | TRIM28 | 1.19663884 |
| 53 | FGFR2 | 1.18789828 |
| 54 | OBSCN | 1.16941061 |
| 55 | CDK19 | 1.16466275 |
| 56 | IRAK3 | 1.13965576 |
| 57 | STK24 | 1.13840920 |
| 58 | PLK1 | 1.12993559 |
| 59 | MST4 | 1.11208544 |
| 60 | CDC7 | 1.10010274 |
| 61 | BMPR2 | 1.09235256 |
| 62 | MYLK | 1.09233541 |
| 63 | STK39 | 1.07995895 |
| 64 | VRK1 | 1.05104051 |
| 65 | LCK | 1.03409095 |
| 66 | SYK | 1.02779877 |
| 67 | CSK | 1.01350282 |
| 68 | PDK2 | 1.00647211 |
| 69 | OXSR1 | 0.98365271 |
| 70 | GRK6 | 0.97808677 |
| 71 | CHUK | 0.97333395 |
| 72 | BRSK2 | 0.96859414 |
| 73 | ACVR1B | 0.95865029 |
| 74 | LRRK2 | 0.91669188 |
| 75 | PRKG2 | 0.90976486 |
| 76 | CDK4 | 0.90817713 |
| 77 | EIF2AK1 | 0.88974258 |
| 78 | BLK | 0.88591551 |
| 79 | MAPK11 | 0.86712567 |
| 80 | SMG1 | 0.86506379 |
| 81 | EIF2AK3 | 0.86107612 |
| 82 | MAP3K6 | 0.85639224 |
| 83 | STK16 | 0.84469543 |
| 84 | GRK1 | 0.84183655 |
| 85 | LYN | 0.81811355 |
| 86 | JAK1 | 0.81355098 |
| 87 | DYRK3 | 0.79742149 |
| 88 | CDK7 | 0.79061578 |
| 89 | CDK6 | 0.78301524 |
| 90 | TSSK6 | 0.78093971 |
| 91 | NUAK1 | 0.77649484 |
| 92 | PINK1 | 0.76577062 |
| 93 | ATR | 0.72673218 |
| 94 | MAPKAPK3 | 0.70567630 |
| 95 | PLK2 | 0.69775874 |
| 96 | FGFR3 | 0.69121376 |
| 97 | ATM | 0.67149746 |
| 98 | HCK | 0.66484186 |
| 99 | CDK3 | 0.65897380 |
| 100 | FGFR1 | 0.65064798 |
| 101 | CDK9 | 0.64367624 |
| 102 | JAK2 | 0.63380394 |
| 103 | MAP3K2 | 0.63285218 |
| 104 | ALK | 0.62915065 |
| 105 | NEK2 | 0.61932785 |
| 106 | MKNK2 | 0.61805115 |
| 107 | MAP3K11 | 0.61446378 |
| 108 | DAPK1 | 0.61045520 |
| 109 | CSNK2A2 | 0.58701016 |
| 110 | MELK | 0.56730697 |
| 111 | TRPM7 | 0.55198425 |
| 112 | AURKB | 0.55141452 |
| 113 | MST1R | 0.55122807 |
| 114 | CHEK2 | 0.54514356 |
| 115 | FRK | 0.53912370 |
| 116 | CSNK1G1 | 0.53037954 |
| 117 | MAPK4 | 0.52979803 |
| 118 | STK4 | 0.52650763 |
| 119 | CHEK1 | 0.51475546 |
| 120 | EIF2AK2 | 0.48589183 |
| 121 | MAP3K4 | 0.47617668 |
| 122 | BUB1 | 0.47044344 |
| 123 | SRPK1 | 0.45885759 |
| 124 | CCNB1 | 0.45828978 |
| 125 | DAPK3 | 0.45301733 |
| 126 | PAK4 | 0.44024828 |
| 127 | MARK3 | 0.43595127 |
| 128 | MAP2K6 | 0.43273518 |
| 129 | RPS6KA5 | 0.42684411 |
| 130 | CSNK2A1 | 0.42572326 |
| 131 | MAPKAPK5 | 0.41610027 |
| 132 | MAP3K8 | 0.41536238 |
| 133 | BRSK1 | 0.41428560 |
| 134 | LATS1 | 0.40610835 |
| 135 | STK3 | 0.40594160 |
| 136 | RPS6KA6 | 0.40581509 |
| 137 | AKT2 | 0.38857069 |
| 138 | PLK4 | 0.38074437 |
| 139 | SCYL2 | 0.36504510 |
| 140 | ERBB3 | 0.35556858 |
| 141 | PTK6 | 0.35477467 |
| 142 | TNK2 | 0.35461272 |
| 143 | PRKAA2 | 0.35131047 |
| 144 | MAP3K10 | 0.34977026 |
| 145 | MAP3K13 | 0.33128168 |
| 146 | TNIK | 0.32456577 |
| 147 | MKNK1 | 0.32099692 |
| 148 | MAP3K5 | 0.32084204 |
| 149 | IGF1R | 0.31287144 |
| 150 | TLK1 | 0.31183701 |
| 151 | TESK2 | 0.31119110 |
| 152 | BCR | 0.26516396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.58284621 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51508500 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43037646 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43022554 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.33475386 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05313260 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.91927304 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91857551 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 1.89167147 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88206444 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82914581 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82796991 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74533870 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72647476 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63882594 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59710500 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.54312683 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53418127 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.53208192 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52971312 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52908558 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49252099 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45967737 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43682100 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43504034 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38817722 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37458247 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36528027 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34440179 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34081777 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33582806 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31832692 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31691190 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31470639 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.30309955 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29185944 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29033212 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24819926 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.22925192 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21602933 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21287483 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.21176390 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20402358 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.19422926 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.19048833 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17318546 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15194081 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15030452 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14417412 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14200235 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12776056 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12409456 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09100580 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08175645 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07977281 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07058757 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05967052 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05845845 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04266310 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02099622 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 1.00814243 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00050316 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97803375 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96574082 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96162924 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92403362 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91857406 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90345076 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.89683567 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87271755 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87159352 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85970878 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85529239 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83985848 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83909159 |
| 76 | Spliceosome_Homo sapiens_hsa03040 | 0.80911032 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80507671 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80478977 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80213979 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79885285 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.79769641 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78942651 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78720406 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78654676 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.77407756 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.73403885 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72485820 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72349339 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.71314282 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71010290 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70862183 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70525470 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70160485 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.69621080 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68984552 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67326332 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67139772 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66704547 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66487231 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66253906 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66133497 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64582382 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.64481908 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64459862 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63820724 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.63589102 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63562457 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63317723 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61700504 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60853908 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60695992 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59934620 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59049724 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58799326 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58509590 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58157359 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57542549 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.56082287 |
| 119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52464365 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52103095 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51343552 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49938285 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.48997275 |
| 124 | Hepatitis B_Homo sapiens_hsa05161 | 0.47400708 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47074994 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47013892 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.45220774 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43632426 |
| 129 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41868470 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39862934 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38123307 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37093347 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32394579 |
| 134 | Asthma_Homo sapiens_hsa05310 | 0.29293351 |

